An interesting method of assessing the direction a stock can take is by monitoring insider purchases ... Aegerion Pharmaceuticals (NASDAQ: AEGR) Aegerion is a biopharmaceutical company involved in the development and …
Lowering risk, while concurrently increasing return, is a fundamental tenet, and automatic benefit, of investing in a …
According to a court filing by his soon-to-be ex-wife, Christina, Jefferies Global Head of Healthcare Sage Kelly (he of “I …
Aegerion Pharmaceuticals Inc : Aegerion Pharmaceuticals announces second quarter 2016 financial results . Q2 non-GAAP loss per share $0.72 . Q2 GAAP loss per share $1.59 . Recorded total net product sales of $44.5 million in Q2 …